Allergan, Pfizer Abandon $160B Merger

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland on paper to reduce its tax bill.

Related Videos